Table of Content

1 Pseudorabies Virus Vaccine Market Overview
1.1 Pseudorabies Virus Vaccine Product Scope
1.2 Pseudorabies Virus Vaccine Segment by Type
1.2.1 Global Pseudorabies Virus Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Inactivated Vaccine
1.2.3 Naturally Deficient Attenuated Vaccine
1.2.4 Genetic Engineering Vaccine
1.3 Pseudorabies Virus Vaccine Segment by Application
1.3.1 Global Pseudorabies Virus Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Pseudorabies Virus Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Pseudorabies Virus Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Pseudorabies Virus Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Pseudorabies Virus Vaccine Price Trends (2016-2027)

2 Pseudorabies Virus Vaccine Estimates and Forecasts by Region
2.1 Global Pseudorabies Virus Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Pseudorabies Virus Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Pseudorabies Virus Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Pseudorabies Virus Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Pseudorabies Virus Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Pseudorabies Virus Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Pseudorabies Virus Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Pseudorabies Virus Vaccine Estimates and Projections (2016-2027)
2.4.3 China Pseudorabies Virus Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Pseudorabies Virus Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Pseudorabies Virus Vaccine Estimates and Projections (2016-2027)
2.4.6 India Pseudorabies Virus Vaccine Estimates and Projections (2016-2027)
3 Global Pseudorabies Virus Vaccine Competition Landscape by Players
3.1 Global Top Pseudorabies Virus Vaccine Players by Sales (2016-2021)
3.2 Global Top Pseudorabies Virus Vaccine Players by Revenue (2016-2021)
3.3 Global Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pseudorabies Virus Vaccine as of 2020)
3.4 Global Pseudorabies Virus Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Pseudorabies Virus Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Pseudorabies Virus Vaccine Market Size by Type
4.1 Global Pseudorabies Virus Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Pseudorabies Virus Vaccine Price by Type (2016-2021)
4.2 Global Pseudorabies Virus Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pseudorabies Virus Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Pseudorabies Virus Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Pseudorabies Virus Vaccine Price Forecast by Type (2022-2027)
5 Global Pseudorabies Virus Vaccine Market Size by Application
5.1 Global Pseudorabies Virus Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Pseudorabies Virus Vaccine Price by Application (2016-2021)
5.2 Global Pseudorabies Virus Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pseudorabies Virus Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Pseudorabies Virus Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Pseudorabies Virus Vaccine Price Forecast by Application (2022-2027)

6 North America Pseudorabies Virus Vaccine Market Facts & Figures
6.1 North America Pseudorabies Virus Vaccine Sales by Company
6.1.1 North America Pseudorabies Virus Vaccine Sales by Company (2016-2021)
6.1.2 North America Pseudorabies Virus Vaccine Revenue by Company (2016-2021)
6.2 North America Pseudorabies Virus Vaccine Sales Breakdown by Type
6.2.1 North America Pseudorabies Virus Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Pseudorabies Virus Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Pseudorabies Virus Vaccine Sales Breakdown by Application
6.3.1 North America Pseudorabies Virus Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Pseudorabies Virus Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Pseudorabies Virus Vaccine Market Facts & Figures
7.1 Europe Pseudorabies Virus Vaccine Sales by Company
7.1.1 Europe Pseudorabies Virus Vaccine Sales by Company (2016-2021)
7.1.2 Europe Pseudorabies Virus Vaccine Revenue by Company (2016-2021)
7.2 Europe Pseudorabies Virus Vaccine Sales Breakdown by Type
7.2.1 Europe Pseudorabies Virus Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Pseudorabies Virus Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Pseudorabies Virus Vaccine Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China Pseudorabies Virus Vaccine Market Facts & Figures
8.1 China Pseudorabies Virus Vaccine Sales by Company
8.1.1 China Pseudorabies Virus Vaccine Sales by Company (2016-2021)
8.1.2 China Pseudorabies Virus Vaccine Revenue by Company (2016-2021)
8.2 China Pseudorabies Virus Vaccine Sales Breakdown by Type
8.2.1 China Pseudorabies Virus Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Pseudorabies Virus Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Pseudorabies Virus Vaccine Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Pseudorabies Virus Vaccine Market Facts & Figures
9.1 Japan Pseudorabies Virus Vaccine Sales by Company
9.1.1 Japan Pseudorabies Virus Vaccine Sales by Company (2016-2021)
9.1.2 Japan Pseudorabies Virus Vaccine Revenue by Company (2016-2021)
9.2 Japan Pseudorabies Virus Vaccine Sales Breakdown by Type
9.2.1 Japan Pseudorabies Virus Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Pseudorabies Virus Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Pseudorabies Virus Vaccine Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Pseudorabies Virus Vaccine Market Facts & Figures
10.1 Southeast Asia Pseudorabies Virus Vaccine Sales by Company
10.1.1 Southeast Asia Pseudorabies Virus Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Pseudorabies Virus Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Pseudorabies Virus Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Pseudorabies Virus Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Pseudorabies Virus Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Pseudorabies Virus Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)

11 India Pseudorabies Virus Vaccine Market Facts & Figures
11.1 India Pseudorabies Virus Vaccine Sales by Company
11.1.1 India Pseudorabies Virus Vaccine Sales by Company (2016-2021)
11.1.2 India Pseudorabies Virus Vaccine Revenue by Company (2016-2021)
11.2 India Pseudorabies Virus Vaccine Sales Breakdown by Type
11.2.1 India Pseudorabies Virus Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Pseudorabies Virus Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Pseudorabies Virus Vaccine Sales Breakdown by Application
11.3.1 India Pseudorabies Virus Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Pseudorabies Virus Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Pseudorabies Virus Vaccine Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Pseudorabies Virus Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 Merial Limited
12.2.1 Merial Limited Corporation Information
12.2.2 Merial Limited Business Overview
12.2.3 Merial Limited Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merial Limited Pseudorabies Virus Vaccine Products Offered
12.2.5 Merial Limited Recent Development
12.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
12.3.1 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Corporation Information
12.3.2 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Business Overview
12.3.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.3.5 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Recent Development
12.4 Zoetis
12.4.1 Zoetis Corporation Information
12.4.2 Zoetis Business Overview
12.4.3 Zoetis Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Zoetis Pseudorabies Virus Vaccine Products Offered
12.4.5 Zoetis Recent Development
12.5 Hipra
12.5.1 Hipra Corporation Information
12.5.2 Hipra Business Overview
12.5.3 Hipra Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hipra Pseudorabies Virus Vaccine Products Offered
12.5.5 Hipra Recent Development
12.6 Anhui Divinity Biological Products
12.6.1 Anhui Divinity Biological Products Corporation Information
12.6.2 Anhui Divinity Biological Products Business Overview
12.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Products Offered
12.6.5 Anhui Divinity Biological Products Recent Development
12.7 Wuhan Keqian Biological Co., Ltd.
12.7.1 Wuhan Keqian Biological Co., Ltd. Corporation Information
12.7.2 Wuhan Keqian Biological Co., Ltd. Business Overview
12.7.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.7.5 Wuhan Keqian Biological Co., Ltd. Recent Development
12.8 China Biotechnology Co., Ltd.
12.8.1 China Biotechnology Co., Ltd. Corporation Information
12.8.2 China Biotechnology Co., Ltd. Business Overview
12.8.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.8.5 China Biotechnology Co., Ltd. Recent Development
12.9 CHINA ANIMAL HUSBANDRY INDUSTRY
12.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Corporation Information
12.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Business Overview
12.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Products Offered
12.9.5 CHINA ANIMAL HUSBANDRY INDUSTRY Recent Development
12.10 Sichuan Huashen
12.10.1 Sichuan Huashen Corporation Information
12.10.2 Sichuan Huashen Business Overview
12.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sichuan Huashen Pseudorabies Virus Vaccine Products Offered
12.10.5 Sichuan Huashen Recent Development
12.11 Haley
12.11.1 Haley Corporation Information
12.11.2 Haley Business Overview
12.11.3 Haley Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Haley Pseudorabies Virus Vaccine Products Offered
12.11.5 Haley Recent Development
12.12 Tianbang
12.12.1 Tianbang Corporation Information
12.12.2 Tianbang Business Overview
12.12.3 Tianbang Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Tianbang Pseudorabies Virus Vaccine Products Offered
12.12.5 Tianbang Recent Development
12.13 Dabei Nong
12.13.1 Dabei Nong Corporation Information
12.13.2 Dabei Nong Business Overview
12.13.3 Dabei Nong Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dabei Nong Pseudorabies Virus Vaccine Products Offered
12.13.5 Dabei Nong Recent Development
12.14 Harvey
12.14.1 Harvey Corporation Information
12.14.2 Harvey Business Overview
12.14.3 Harvey Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Harvey Pseudorabies Virus Vaccine Products Offered
12.14.5 Harvey Recent Development
12.15 Preh Bio
12.15.1 Preh Bio Corporation Information
12.15.2 Preh Bio Business Overview
12.15.3 Preh Bio Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Preh Bio Pseudorabies Virus Vaccine Products Offered
12.15.5 Preh Bio Recent Development
12.16 Jiangsu Nannong High-Tech Co.
12.16.1 Jiangsu Nannong High-Tech Co. Corporation Information
12.16.2 Jiangsu Nannong High-Tech Co. Business Overview
12.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Products Offered
12.16.5 Jiangsu Nannong High-Tech Co. Recent Development
12.17 Guangxi Liyuan Biological Co., Ltd.
12.17.1 Guangxi Liyuan Biological Co., Ltd. Corporation Information
12.17.2 Guangxi Liyuan Biological Co., Ltd. Business Overview
12.17.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.17.5 Guangxi Liyuan Biological Co., Ltd. Recent Development
12.18 Jilin Zhengye Bioengineering Group
12.18.1 Jilin Zhengye Bioengineering Group Corporation Information
12.18.2 Jilin Zhengye Bioengineering Group Business Overview
12.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Products Offered
12.18.5 Jilin Zhengye Bioengineering Group Recent Development
12.19 Jilin Heyuan Biological Engineering Co., Ltd.
12.19.1 Jilin Heyuan Biological Engineering Co., Ltd. Corporation Information
12.19.2 Jilin Heyuan Biological Engineering Co., Ltd. Business Overview
12.19.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.19.5 Jilin Heyuan Biological Engineering Co., Ltd. Recent Development
12.20 Huapai Biological Engineering Group Co., Ltd.
12.20.1 Huapai Biological Engineering Group Co., Ltd. Corporation Information
12.20.2 Huapai Biological Engineering Group Co., Ltd. Business Overview
12.20.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.20.5 Huapai Biological Engineering Group Co., Ltd. Recent Development
12.21 Beijing Xinde Weite Technology Co., Ltd.
12.21.1 Beijing Xinde Weite Technology Co., Ltd. Corporation Information
12.21.2 Beijing Xinde Weite Technology Co., Ltd. Business Overview
12.21.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.21.5 Beijing Xinde Weite Technology Co., Ltd. Recent Development
12.22 Beijing Veterinary Biopharmaceutical Factory
12.22.1 Beijing Veterinary Biopharmaceutical Factory Corporation Information
12.22.2 Beijing Veterinary Biopharmaceutical Factory Business Overview
12.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Products Offered
12.22.5 Beijing Veterinary Biopharmaceutical Factory Recent Development
12.23 Qilu Animal Health Products Co., Ltd.
12.23.1 Qilu Animal Health Products Co., Ltd. Corporation Information
12.23.2 Qilu Animal Health Products Co., Ltd. Business Overview
12.23.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.23.5 Qilu Animal Health Products Co., Ltd. Recent Development
12.24 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
12.24.1 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Corporation Information
12.24.2 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Business Overview
12.24.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.24.5 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Recent Development
12.25 Yunnan Biopharmaceutical Co.
12.25.1 Yunnan Biopharmaceutical Co. Corporation Information
12.25.2 Yunnan Biopharmaceutical Co. Business Overview
12.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Products Offered
12.25.5 Yunnan Biopharmaceutical Co. Recent Development
12.26 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
12.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Corporation Information
12.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Business Overview
12.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.26.5 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Recent Development
12.27 Liaoning Yikang Biological Co., Ltd.
12.27.1 Liaoning Yikang Biological Co., Ltd. Corporation Information
12.27.2 Liaoning Yikang Biological Co., Ltd. Business Overview
12.27.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.27.5 Liaoning Yikang Biological Co., Ltd. Recent Development
12.28 Shanghui Huahong Biological Engineering Co., Ltd.
12.28.1 Shanghui Huahong Biological Engineering Co., Ltd. Corporation Information
12.28.2 Shanghui Huahong Biological Engineering Co., Ltd. Business Overview
12.28.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.28.4 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.28.5 Shanghui Huahong Biological Engineering Co., Ltd. Recent Development
12.29 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
12.29.1 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Corporation Information
12.29.2 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Business Overview
12.29.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.29.4 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.29.5 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Recent Development
12.30 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
12.30.1 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Corporation Information
12.30.2 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Business Overview
12.30.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.30.4 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Products Offered
12.30.5 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Recent Development

13 Pseudorabies Virus Vaccine Manufacturing Cost Analysis
13.1 Pseudorabies Virus Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pseudorabies Virus Vaccine
13.4 Pseudorabies Virus Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pseudorabies Virus Vaccine Distributors List
14.3 Pseudorabies Virus Vaccine Customers

15 Market Dynamics
15.1 Pseudorabies Virus Vaccine Market Trends
15.2 Pseudorabies Virus Vaccine Drivers
15.3 Pseudorabies Virus Vaccine Market Challenges
15.4 Pseudorabies Virus Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pseudorabies Virus Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Pseudorabies Virus Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Pseudorabies Virus Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Pseudorabies Virus Vaccine Sales (M Doses) by Region (2016-2021)
Table 5. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Pseudorabies Virus Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Pseudorabies Virus Vaccine Sales (M Doses) Forecast by Region (2022-2027)
Table 9. Global Pseudorabies Virus Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Pseudorabies Virus Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Pseudorabies Virus Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 13. Global Pseudorabies Virus Vaccine Sales Share by Company (2016-2021)
Table 14. Global Pseudorabies Virus Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Pseudorabies Virus Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Pseudorabies Virus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudorabies Virus Vaccine as of 2020)
Table 17. Global Pseudorabies Virus Vaccine Average Price (USD/Doses) of Key Company (2016-2021)
Table 18. Manufacturers Pseudorabies Virus Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Pseudorabies Virus Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Pseudorabies Virus Vaccine Sales (M Doses) by Type (2016-2021)
Table 22. Global Pseudorabies Virus Vaccine Sales Share by Type (2016-2021)
Table 23. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Pseudorabies Virus Vaccine Price (USD/Doses) by Type (2016-2021)
Table 25. Global Pseudorabies Virus Vaccine Sales Share by Type (2022-2027)
Table 26. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Pseudorabies Virus Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Pseudorabies Virus Vaccine Price (USD/Doses) by Type (2022-2027)
Table 29. Global Pseudorabies Virus Vaccine Sales (M Doses) by Application (2016-2021)
Table 30. Global Pseudorabies Virus Vaccine Sales Share by Application (2016-2021)
Table 31. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Pseudorabies Virus Vaccine Price (USD/Doses) by Application (2016-2021)
Table 33. Global Pseudorabies Virus Vaccine Sales (M Doses) by Application (2022-2027)
Table 34. Global Pseudorabies Virus Vaccine Sales Share by Application (2022-2027)
Table 35. Global Pseudorabies Virus Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Pseudorabies Virus Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Pseudorabies Virus Vaccine Price (USD/Doses) by Application (2022-2027)
Table 38. North America Pseudorabies Virus Vaccine Sales (M Doses) by Company (2016-2021)
Table 39. North America Pseudorabies Virus Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Pseudorabies Virus Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Pseudorabies Virus Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Pseudorabies Virus Vaccine Sales by Type (2016-2021) & (M Doses)
Table 43. North America Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Pseudorabies Virus Vaccine Sales by Type (2022-2027) & (M Doses)
Table 45. North America Pseudorabies Virus Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Pseudorabies Virus Vaccine Sales by Application (2016-2021) & (M Doses)
Table 47. North America Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Pseudorabies Virus Vaccine Sales by Application (2022-2027) & (M Doses)
Table 49. North America Pseudorabies Virus Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Pseudorabies Virus Vaccine Sales (M Doses) by Company (2016-2021)
Table 51. Europe Pseudorabies Virus Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Pseudorabies Virus Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Pseudorabies Virus Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Pseudorabies Virus Vaccine Sales by Type (2016-2021) & (M Doses)
Table 55. Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Pseudorabies Virus Vaccine Sales by Type (2022-2027) & (M Doses)
Table 57. Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Pseudorabies Virus Vaccine Sales by Application (2016-2021) & (M Doses)
Table 59. Europe Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Pseudorabies Virus Vaccine Sales by Application (2022-2027) & (M Doses)
Table 61. Europe Pseudorabies Virus Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Pseudorabies Virus Vaccine Sales (M Doses) by Company (2016-2021)
Table 63. China Pseudorabies Virus Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Pseudorabies Virus Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Pseudorabies Virus Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Pseudorabies Virus Vaccine Sales by Type (2016-2021) & (M Doses)
Table 67. China Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Pseudorabies Virus Vaccine Sales by Type (2022-2027) & (M Doses)
Table 69. China Pseudorabies Virus Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Pseudorabies Virus Vaccine Sales by Application (2016-2021) & (M Doses)
Table 71. China Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Pseudorabies Virus Vaccine Sales by Application (2022-2027) & (M Doses)
Table 73. China Pseudorabies Virus Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Pseudorabies Virus Vaccine Sales (M Doses) by Company (2016-2021)
Table 75. Japan Pseudorabies Virus Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Pseudorabies Virus Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Pseudorabies Virus Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Pseudorabies Virus Vaccine Sales by Type (2016-2021) & (M Doses)
Table 79. Japan Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Pseudorabies Virus Vaccine Sales by Type (2022-2027) & (M Doses)
Table 81. Japan Pseudorabies Virus Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Pseudorabies Virus Vaccine Sales by Application (2016-2021) & (M Doses)
Table 83. Japan Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Pseudorabies Virus Vaccine Sales by Application (2022-2027) & (M Doses)
Table 85. Japan Pseudorabies Virus Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Pseudorabies Virus Vaccine Sales (M Doses) by Company (2016-2021)
Table 87. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Pseudorabies Virus Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Pseudorabies Virus Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Pseudorabies Virus Vaccine Sales by Type (2016-2021) & (M Doses)
Table 91. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Pseudorabies Virus Vaccine Sales by Type (2022-2027) & (M Doses)
Table 93. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Pseudorabies Virus Vaccine Sales by Application (2016-2021) & (M Doses)
Table 95. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Pseudorabies Virus Vaccine Sales by Application (2022-2027) & (M Doses)
Table 97. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Pseudorabies Virus Vaccine Sales (M Doses) by Company (2016-2021)
Table 99. India Pseudorabies Virus Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Pseudorabies Virus Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Pseudorabies Virus Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Pseudorabies Virus Vaccine Sales by Type (2016-2021) & (M Doses)
Table 103. India Pseudorabies Virus Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Pseudorabies Virus Vaccine Sales by Type (2022-2027) & (M Doses)
Table 105. India Pseudorabies Virus Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Pseudorabies Virus Vaccine Sales by Application (2016-2021) & (M Doses)
Table 107. India Pseudorabies Virus Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Pseudorabies Virus Vaccine Sales by Application (2022-2027) & (M Doses)
Table 109. India Pseudorabies Virus Vaccine Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 113. Merck Pseudorabies Virus Vaccine Product
Table 114. Merck Recent Development
Table 115. Merial Limited Corporation Information
Table 116. Merial Limited Description and Business Overview
Table 117. Merial Limited Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 118. Merial Limited Pseudorabies Virus Vaccine Product
Table 119. Merial Limited Recent Development
Table 120. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Corporation Information
Table 121. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Description and Business Overview
Table 122. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product
Table 124. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Recent Development
Table 125. Zoetis Corporation Information
Table 126. Zoetis Description and Business Overview
Table 127. Zoetis Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 128. Zoetis Pseudorabies Virus Vaccine Product
Table 129. Zoetis Recent Development
Table 130. Hipra Corporation Information
Table 131. Hipra Description and Business Overview
Table 132. Hipra Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 133. Hipra Pseudorabies Virus Vaccine Product
Table 134. Hipra Recent Development
Table 135. Anhui Divinity Biological Products Corporation Information
Table 136. Anhui Divinity Biological Products Description and Business Overview
Table 137. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 138. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product
Table 139. Anhui Divinity Biological Products Recent Development
Table 140. Wuhan Keqian Biological Co., Ltd. Corporation Information
Table 141. Wuhan Keqian Biological Co., Ltd. Description and Business Overview
Table 142. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 143. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product
Table 144. Wuhan Keqian Biological Co., Ltd. Recent Development
Table 145. China Biotechnology Co., Ltd. Corporation Information
Table 146. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 147. China Biotechnology Co., Ltd. Description and Business Overview
Table 148. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product
Table 149. China Biotechnology Co., Ltd. Recent Development
Table 150. CHINA ANIMAL HUSBANDRY INDUSTRY Corporation Information
Table 151. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 152. CHINA ANIMAL HUSBANDRY INDUSTRY Description and Business Overview
Table 153. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product
Table 154. CHINA ANIMAL HUSBANDRY INDUSTRY Recent Development
Table 155. Sichuan Huashen Corporation Information
Table 156. Sichuan Huashen Description and Business Overview
Table 157. Sichuan Huashen Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 158. Sichuan Huashen Pseudorabies Virus Vaccine Product
Table 159. Sichuan Huashen Recent Development
Table 160. Haley Corporation Information
Table 161. Haley Description and Business Overview
Table 162. Haley Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 163. Haley Pseudorabies Virus Vaccine Product
Table 164. Haley Recent Development
Table 165. Tianbang Corporation Information
Table 166. Tianbang Description and Business Overview
Table 167. Tianbang Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 168. Tianbang Pseudorabies Virus Vaccine Product
Table 169. Tianbang Recent Development
Table 170. Dabei Nong Corporation Information
Table 171. Dabei Nong Description and Business Overview
Table 172. Dabei Nong Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 173. Dabei Nong Pseudorabies Virus Vaccine Product
Table 174. Dabei Nong Recent Development
Table 175. Harvey Corporation Information
Table 176. Harvey Description and Business Overview
Table 177. Harvey Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 178. Harvey Pseudorabies Virus Vaccine Product
Table 179. Harvey Recent Development
Table 180. Preh Bio Corporation Information
Table 181. Preh Bio Description and Business Overview
Table 182. Preh Bio Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 183. Preh Bio Pseudorabies Virus Vaccine Product
Table 184. Preh Bio Recent Development
Table 185. Jiangsu Nannong High-Tech Co. Corporation Information
Table 186. Jiangsu Nannong High-Tech Co. Description and Business Overview
Table 187. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 188. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product
Table 189. Jiangsu Nannong High-Tech Co. Recent Development
Table 190. Guangxi Liyuan Biological Co., Ltd. Corporation Information
Table 191. Guangxi Liyuan Biological Co., Ltd. Description and Business Overview
Table 192. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 193. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product
Table 194. Guangxi Liyuan Biological Co., Ltd. Recent Development
Table 195. Jilin Zhengye Bioengineering Group Corporation Information
Table 196. Jilin Zhengye Bioengineering Group Description and Business Overview
Table 197. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 198. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product
Table 199. Jilin Zhengye Bioengineering Group Recent Development
Table 200. Jilin Heyuan Biological Engineering Co., Ltd. Corporation Information
Table 201. Jilin Heyuan Biological Engineering Co., Ltd. Description and Business Overview
Table 202. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 203. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product
Table 204. Jilin Heyuan Biological Engineering Co., Ltd. Recent Development
Table 205. Huapai Biological Engineering Group Co., Ltd. Corporation Information
Table 206. Huapai Biological Engineering Group Co., Ltd. Description and Business Overview
Table 207. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 208. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product
Table 209. Huapai Biological Engineering Group Co., Ltd. Recent Development
Table 210. Beijing Xinde Weite Technology Co., Ltd. Corporation Information
Table 211. Beijing Xinde Weite Technology Co., Ltd. Description and Business Overview
Table 212. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 213. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product
Table 214. Beijing Xinde Weite Technology Co., Ltd. Recent Development
Table 215. Beijing Veterinary Biopharmaceutical Factory Corporation Information
Table 216. Beijing Veterinary Biopharmaceutical Factory Description and Business Overview
Table 217. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 218. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product
Table 219. Beijing Veterinary Biopharmaceutical Factory Recent Development
Table 220. Qilu Animal Health Products Co., Ltd. Corporation Information
Table 221. Qilu Animal Health Products Co., Ltd. Description and Business Overview
Table 222. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 223. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product
Table 224. Qilu Animal Health Products Co., Ltd. Recent Development
Table 225. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Corporation Information
Table 226. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Description and Business Overview
Table 227. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 228. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table 229. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Recent Development
Table 230. Yunnan Biopharmaceutical Co. Corporation Information
Table 231. Yunnan Biopharmaceutical Co. Description and Business Overview
Table 232. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 233. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product
Table 234. Yunnan Biopharmaceutical Co. Recent Development
Table 235. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Corporation Information
Table 236. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table 237. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 238. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table 239. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Recent Development
Table 240. Liaoning Yikang Biological Co., Ltd. Corporation Information
Table 241. Liaoning Yikang Biological Co., Ltd. Description and Business Overview
Table 242. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 243. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product
Table 244. Liaoning Yikang Biological Co., Ltd. Recent Development
Table 245. Shanghui Huahong Biological Engineering Co., Ltd. Corporation Information
Table 246. Shanghui Huahong Biological Engineering Co., Ltd. Description and Business Overview
Table 247. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 248. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product
Table 249. Shanghui Huahong Biological Engineering Co., Ltd. Recent Development
Table 250. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Corporation Information
Table 251. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table 252. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 253. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table 254. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Recent Development
Table 255. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Corporation Information
Table 256. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table 257. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 258. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product
Table 259. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Recent Development
Table 260. Production Base and Market Concentration Rate of Raw Material
Table 261. Key Suppliers of Raw Materials
Table 262. Pseudorabies Virus Vaccine Distributors List
Table 263. Pseudorabies Virus Vaccine Customers List
Table 264. Pseudorabies Virus Vaccine Market Trends
Table 265. Pseudorabies Virus Vaccine Market Drivers
Table 266. Pseudorabies Virus Vaccine Market Challenges
Table 267. Pseudorabies Virus Vaccine Market Restraints
Table 268. Research Programs/Design for This Report
Table 269. Key Data Information from Secondary Sources
Table 270. Key Data Information from Primary Sources
List of Figures
Figure 1. Pseudorabies Virus Vaccine Product Picture
Figure 2. Global Pseudorabies Virus Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pseudorabies Virus Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Government Tender Examples
Figure 7. Market Sales Examples
Figure 8. Global Pseudorabies Virus Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Pseudorabies Virus Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Pseudorabies Virus Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 11. Global Pseudorabies Virus Vaccine Price Trends Growth Rate (2016-2027) (USD/Doses)
Figure 12. Global Pseudorabies Virus Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Pseudorabies Virus Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Pseudorabies Virus Vaccine Sales (M Doses) Growth Rate (2016-2027)
Figure 16. Europe Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Pseudorabies Virus Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Pseudorabies Virus Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Pseudorabies Virus Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Pseudorabies Virus Vaccine Players Market Share by Revenue in Pseudorabies Virus Vaccine: 2016 & 2020
Figure 27. Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Pseudorabies Virus Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Pseudorabies Virus Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Pseudorabies Virus Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Pseudorabies Virus Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Pseudorabies Virus Vaccine Sales Market Share by Type in 2020
Figure 33. North America Pseudorabies Virus Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Pseudorabies Virus Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Pseudorabies Virus Vaccine Sales Market Share by Application in 2020
Figure 36. China Pseudorabies Virus Vaccine Sales Market Share by Type in 2020
Figure 37. China Pseudorabies Virus Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Pseudorabies Virus Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Pseudorabies Virus Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Pseudorabies Virus Vaccine Sales Market Share by Application in 2020
Figure 42. India Pseudorabies Virus Vaccine Sales Market Share by Type in 2020
Figure 43. India Pseudorabies Virus Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Pseudorabies Virus Vaccine
Figure 46. Manufacturing Process Analysis of Pseudorabies Virus Vaccine
Figure 47. Pseudorabies Virus Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed